Krishna Institute of Medical Sciences Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 88.0. ROE: 18.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on Q3 FY26 earnings • Updated Feb 22, 2026
What: Nasik already EBITDA positive; Bangalore Electronic City targeting breakeven by Q3 FY27
Impact: +₹100 Cr revenue
“We've achieved almost 8 and a half crore revenue and we turned EBITDA positive. We got empowerment of ECHS in Nasik. - Abhinay Bollineni”
What: 5% growth in mature clusters considered healthy; Andhra Pradesh recovering from strike
Impact: +₹50 Cr revenue
“January things have bounced back and the revenues are as per how it was in Q2. - Sreenath Reddy”
What: All capex for current expansion cycle completed; focus shifts to operational efficiency
“All the capex for all the three hospitals are fully done. There is no incremental capex that we have to incur for more beds up to each of their capacities. - Abhinay Bollineni”
Earnings deceleration risks from management commentary
Trigger: Occupancy below 60%
Impact: -300 bps margin impact
Management view: The decline in EBITDA was mainly on account of EBITDA erosion caused by the newer units that commenced operations over the last 9 to 12 months.
Monitor: New hospital occupancy rates
Trigger: Policy changes/strikes
Impact: -200 bps margin impact
Management view: As far as Andhra in quarter three we had a strike with the state government. So we had not taken advocacy scheme for almost a month.
Monitor: State government scheme participation
Key quotes from recent conference calls
“We have enough capacity operationalized in all of these hospitals. All the capex for all the three hospitals are fully done. There is no incremental capex that we have to incur for more beds up to each of their capacities. — Abhinay Bollineni”
“The decline in EBITDA was mainly on account of EBITDA erosion caused by the newer units that commenced operations over the last 9 to 12 months. — Management”
“Average revenue per operating bed grew by 20.5% and 10.3% on year on year and quarter on quarter basis respectively. Average revenue per patient grew by 13.9% and 9% on year on year and quarter on quarter basis respectively. — Management”
“We are targeting [breakeven for Electronic City] somewhere in the second quarter of the financial year. — Abhinay Bollineni”
Forward-looking targets from management for Next 2-4 quarters
Revenue Growth Target
25%
Implied PAT Growth
30%
OPM Guidance
22%
Capex Plan
₹0 Cr
Key Milestones
• Nasik breakeven achieved
• Bangalore Electronic City breakeven by Q3 FY27
• Andhra Pradesh volume recovery
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Feb 22, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Krishna Institute of Medical Sciences Ltd's latest quarterly results (Dec 2025) show
Krishna Institute of Medical Sciences Ltd's current PE ratio is 88.0x.
Krishna Institute of Medical Sciences Ltd's price-to-book ratio is 11.4x.
Krishna Institute of Medical Sciences Ltd's fundamental strength based on key financial ratios
Krishna Institute of Medical Sciences Ltd has a debt-to-equity ratio of N/A.
Krishna Institute of Medical Sciences Ltd's return ratios over recent years
Krishna Institute of Medical Sciences Ltd's operating cash flow is positive (FY2025).
Krishna Institute of Medical Sciences Ltd currently does not pay a significant dividend (yield 0.00%).
Krishna Institute of Medical Sciences Ltd's shareholding pattern (Dec 2025)
Krishna Institute of Medical Sciences Ltd's promoter holding has remained stable recently.
Krishna Institute of Medical Sciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Krishna Institute of Medical Sciences Ltd has 3 key growth catalysts identified from recent earnings analysis
Krishna Institute of Medical Sciences Ltd has 2 key risks worth monitoring
In Q3 FY26, Krishna Institute of Medical Sciences Ltd's management highlighted
Krishna Institute of Medical Sciences Ltd's management has provided the following forward guidance for Next 2-4 quarters
Based on quantitative research signals, here is why Krishna Institute of Medical Sciences Ltd may be worth studying
Krishna Institute of Medical Sciences Ltd investment thesis summary:
Krishna Institute of Medical Sciences Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
